BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ebrahimi V, Soleimanian A, Ebrahimi T, Azargun R, Yazdani P, Eyvazi S, Tarhriz V. Epigenetic modifications in gastric cancer: Focus on DNA methylation. Gene 2020;742:144577. [DOI: 10.1016/j.gene.2020.144577] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Yin H, Zhao W, Ai S. Electrochemical, electrochemiluminescent and photoelectrochemical bioanalysis of epigenetic modifiers: A comprehensive review. Coordination Chemistry Reviews 2020;424:213519. [DOI: 10.1016/j.ccr.2020.213519] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 9.5] [Reference Citation Analysis]
2 Bidar N, Rezaei T, Amini M, Jebelli A, Mokhtarzadeh A, Baradaran B. ZNF677 downregulation by promoter hypermethylation as a driver event through gastric tumorigenesis. Exp Mol Pathol 2021;121:104663. [PMID: 34171355 DOI: 10.1016/j.yexmp.2021.104663] [Reference Citation Analysis]
3 Ebrahimzadeh S, Ahangari H, Soleimanian A, Hosseini K, Ebrahimi V, Ghasemnejad T, Soofiyani SR, Tarhriz V, Eyvazi S. Colorectal cancer treatment using bacteria: focus on molecular mechanisms. BMC Microbiol 2021;21:218. [PMID: 34281519 DOI: 10.1186/s12866-021-02274-3] [Reference Citation Analysis]
4 Canale M, Casadei-Gardini A, Ulivi P, Arechederra M, Berasain C, Lollini PL, Fernández-Barrena MG, Avila MA. Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities. Int J Mol Sci 2020;21:E5500. [PMID: 32752096 DOI: 10.3390/ijms21155500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Bagheri Y, Sadigh-Eteghad S, Fathi E, Mahmoudi J, Abdollahpour A, Namini NJ, Malekinejad Z, Mokhtari K, Barati A, Montazersaheb S. Hepatoprotective effects of sericin on aging-induced liver damage in mice. Naunyn Schmiedebergs Arch Pharmacol 2021;394:2441-50. [PMID: 34605941 DOI: 10.1007/s00210-021-02160-9] [Reference Citation Analysis]
6 Nemtsova MV, Mikhaylenko DS, Kuznetsova EB, Bykov II, Zamyatnin AA Jr. Inactivation of Epigenetic Regulators due to Mutations in Solid Tumors. Biochemistry (Mosc) 2020;85:735-48. [PMID: 33040718 DOI: 10.1134/S0006297920070020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Chen J, Liu W, Du J, Wang P, Wang J, Ye K. Comprehensive Genomic and Epigenomic Analyses on Transcriptomic Regulation in Stomach Adenocarcinoma. Front Genet 2022;12:778095. [DOI: 10.3389/fgene.2021.778095] [Reference Citation Analysis]
8 Zeng Y, Rong H, Xu J, Cao R, Li S, Gao Y, Cheng B, Zhou T. DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer. Front Genet 2022;13:823905. [DOI: 10.3389/fgene.2022.823905] [Reference Citation Analysis]
9 Yusuf AP, Abubakar MB, Malami I, Ibrahim KG, Abubakar B, Bello MB, Qusty N, Elazab ST, Imam MU, Alexiou A, Batiha GE. Zinc Metalloproteins in Epigenetics and Their Crosstalk. Life (Basel) 2021;11:186. [PMID: 33652690 DOI: 10.3390/life11030186] [Reference Citation Analysis]
10 Wen J, Deng S, Bi Y, Qiao L, Xu H. Association between multiple gene promoter hypermethylation and the risk of gastric cancer: A systematic review and meta-analysis. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.03.009] [Reference Citation Analysis]
11 Gao C, Liu H, Zhao Y, Miao X, Zheng H. Is there a relationship between neural EGFL like 1 (NELL1) promoter hypermethylation and prognosis of gastric cancer? Med Hypotheses 2021;158:110723. [PMID: 34753006 DOI: 10.1016/j.mehy.2021.110723] [Reference Citation Analysis]
12 Camero S, Vitali G, Pontecorvi P, Ceccarelli S, Anastasiadou E, Cicchetti F, Flex E, Pomella S, Cassandri M, Rota R, Marampon F, Marchese C, Schiavetti A, Megiorni F. DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma. Cells 2021;10:2956. [PMID: 34831178 DOI: 10.3390/cells10112956] [Reference Citation Analysis]
13 Huang ZB, Zhang HT, Yu B, Yu DH. Cell-free DNA as a liquid biopsy for early detection of gastric cancer. Oncol Lett 2021;21:3. [PMID: 33240409 DOI: 10.3892/ol.2020.12264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Huang F, Jiang J, Yao Y, Hu S, Wang H, Zhu M, Yu L, Liu Q, Jia H, Xu W. Circular RNA Hsa_circRNA_101996 promotes the development of Gastric Cancer via Upregulating Matrix Metalloproteinases-2/Matrix Metalloproteinases-9 through MicroRNA-143/Ten-eleven translocation-2 Pathway. J Cancer 2021;12:6665-75. [PMID: 34659556 DOI: 10.7150/jca.62121] [Reference Citation Analysis]
15 Sadeghi-Amiri L, Barzegar A, Nikbakhsh-Zati N, Mehraban P. Hypomethylation of the XRE -1383 site is associated with the upregulation of CYP1A1 in gastric adenocarcinoma. Gene 2021;769:145216. [PMID: 33069801 DOI: 10.1016/j.gene.2020.145216] [Reference Citation Analysis]
16 Xu Q, Hu Y, Chen S, Zhu Y, Li S, Shen F, Guo Y, Sun T, Chen X, Jiang J, Huang W. Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma. Front Mol Biosci 2021;8:683240. [PMID: 34124163 DOI: 10.3389/fmolb.2021.683240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Xu G, Fan L, Zhao S, OuYang C. Neuronal pentraxin II (NPTX2) hypermethylation promotes cell proliferation but inhibits cell cycle arrest and apoptosis in gastric cancer cells by suppressing the p53 signaling pathway. Bioengineered 2021;12:1311-23. [PMID: 33896384 DOI: 10.1080/21655979.2021.1915658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhang C, Li YZ, Dai DQ. Aberrant DNA Methylation-Mediated FOXF2 Dysregulation Is a Prognostic Risk Factor for Gastric Cancer. Front Mol Biosci 2021;8:645470. [PMID: 34568422 DOI: 10.3389/fmolb.2021.645470] [Reference Citation Analysis]
19 Razi Soofiyani S, Ahangari H, Soleimanian A, Babaei G, Ghasemnejad T, Safavi SE, Eyvazi S, Tarhriz V. The role of circadian genes in the pathogenesis of colorectal cancer. Gene 2021;804:145894. [PMID: 34418469 DOI: 10.1016/j.gene.2021.145894] [Reference Citation Analysis]
20 Wang H, Li NS, He C, Xie C, Zhu Y, Lu NH, Hu Y. Discovery and Validation of Novel Methylation Markers in Helicobacter pylori-Associated Gastric Cancer. Dis Markers 2021;2021:4391133. [PMID: 34925643 DOI: 10.1155/2021/4391133] [Reference Citation Analysis]
21 Hu D, Lou X, Meng N, Li Z, Teng Y, Zou Y, Wang F. Peripheral Blood-Based DNA Methylation of Long Non-Coding RNA H19 and Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promoters are Potential Non-Invasive Biomarkers for Gastric Cancer Detection. Cancer Control 2021;28:10732748211043667. [PMID: 34615385 DOI: 10.1177/10732748211043667] [Reference Citation Analysis]
22 Li T, Chen X, Gu M, Deng A, Qian C. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis. Clin Epigenetics 2020;12:161. [PMID: 33115518 DOI: 10.1186/s13148-020-00940-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Xie N, Bai Y, Qiao L, Bai Y, Wu J, Li Y, Jiang M, Xu B, Ni Z, Yuan T, Shi Y, Wu K, Xu F, Wang J, Dong L, Liu N. ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments. J Cell Mol Med 2021;25:4014-27. [PMID: 33724652 DOI: 10.1111/jcmm.16366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Wang Y, Xu L, Ai D. A Sparse and Low-Rank Regression Model for Identifying the Relationships Between DNA Methylation and Gene Expression Levels in Gastric Cancer and the Prediction of Prognosis. Genes (Basel) 2021;12:854. [PMID: 34199440 DOI: 10.3390/genes12060854] [Reference Citation Analysis]
25 Huang G, Zhang J, Gong L, Liu D, Wang X, Chen Y, Guo S. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns. Med Sci Monit 2021;27:e929524. [PMID: 33661858 DOI: 10.12659/MSM.929524] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Takeuchi C, Sato J, Yamashita S, Sasaki A, Akahane T, Aoki R, Yamamichi M, Liu YY, Ito M, Furuta T, Nakajima S, Sakaguchi Y, Takahashi Y, Tsuji Y, Niimi K, Tomida S, Fujishiro M, Yamamichi N, Ushijima T. Autoimmune gastritis induces aberrant DNA methylation reflecting its carcinogenic potential. J Gastroenterol 2022. [PMID: 35034200 DOI: 10.1007/s00535-021-01848-2] [Reference Citation Analysis]